Amyotrophic Lateral Sclerosis Treatment Market Size, Revenue, Growth, Trend & Forecast Analysis, 2020 - 2027, By Distribution Channel, By Treatment, By Country, & By Region

  • Report Id: HCDHR 1939
  • Published Date: August, 2020
  • No of Pages: 150
  • Format: Electronic (PDF)
  • Publisher: DataHorizzon Research
  • Category:

Amyotrophic Lateral Sclerosis Treatment Market Report Overview

Amyotrophic lateral sclerosis treatment market garnered a revenue of USD 674.5 million in the year 2019 globally and has been foreseen to yield USD 949.5 million by the year 2027 at a compound annual growth (CAGR) of 5.1% over the forecast period. The market has been observed to be growing at a steady growth rate over the last three years, however with the impact of COVID-19 pandemic globally, the business conditions are expected to change. The market size may reduce significantly or increase with a spike depending on how the value chain has been affected in the entire process.

Players that are operational in the market for a longer period of time are anticipated to absorb the sudden changes, losses and increased operational costs better than those who have recently entered the market. The report focuses on numerous factors that are anticipated to impact the market growth directly and indirectly. The report categorically analyses the growth patterns of different segments based on multiple derivation models.

Both the qualitative and quantitative aspects have been covered under the report. The amyotrophic lateral sclerosis treatment market report includes market size, drivers, restraints, opportunities and trends that will help you understand the market dynamics in detail. Moreover, the report will include market estimates & forecasts in terms of revenue for the overall market along with the segments mentioned in the study. The report focuses on providing a holistic view of the entire market scenario from multiple unmatched detailed analysis mentioned in the report.

What to expect from the report?

  • Amyotrophic Lateral Sclerosis Treatment Total Available Market (TAM) Size
  • Amyotrophic Lateral Sclerosis Treatment Serviceable Available Market (SAM) Size
  • Business Implications of COVID-19 on the Overall Market
  • Market Share/ Revenue Share (%) of Top Market Players in Total Market Size (2019)
  • Market Size & Forecast (2016-2027) At Country & Regional Level, By Segments
  • Overview & Analysis of Key Players Operating in the Market

Key Highlights: 

Parameters

Description

COVID-19

Impact of COVID-19 on overall business scenario

Amyotrophic Lateral Sclerosis Treatment Market Revenue 2020

Global market revenue in 2020 will be derived taking into various micro & macro level factors; along with COVID-19 pandemic

Competitive Analysis

Company Market Share Analysis, 2019 (%)

Supply Chain Analysis

Analysis pertaining to several participants of supply chain such as raw material suppliers, distributors, & OEMs along with others will be highlighted in the study

Data Source

Primary & Secondary Research, Internal Data Base & Company Annual Reports

Regions Included

North America, Europe, Asia Pacific, Latin America, & Middle East & Africa

Countries Included

U.S., Canada, U.K., Germany, France, Mexico, Brazil, China, India, Japan, South Korea, UAE, South Africa

Table of Contents
Chapter 1. Research Methodology & Data Sources
1.1. Data Analysis Models
1.2. Research Scope & Assumptions
1.3. List of Primary & Secondary Data Sources
Chapter 2. Executive Summary
Chapter 3. Amyotrophic Lateral Sclerosis Treatment Market: Industry Analysis
3.1. Market segmentation
3.2. Supply chain analysis
3.3. Porter’s 5 forces analysis
3.4. PEST analysis
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Market opportunity analysis
3.6. Company Market Share Analysis, 2019
Chapter 4. Amyotrophic Lateral Sclerosis Treatment Market: Distribution Channel Insights
4.1. Global Distribution Channel Historic Market Data & Future Forecasts, 2016-2027
4.2. Hospital Pharmacies
4.2.1. Historic Market Data & Future Forecasts, 2016-2027
4.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.3. Retail Pharmacies
4.3.1. Historic Market Data & Future Forecasts, 2016-2027
4.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4. Others
4.4.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 5. Amyotrophic Lateral Sclerosis Treatment Market: Treatment Insights
5.1. Global Treatment Historic Market Data & Future Forecasts, 2016-2027
5.2. Medication
5.2.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.3. Stem Cell Therapy
5.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.4. Others
5.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 6. Amyotrophic Lateral Sclerosis Treatment Market: Regional Insights
6.1. Global Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Region 2016-2027
6.2. North America
6.2.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.2.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
6.2.4. U.S.
6.2.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.4.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.2.4.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
6.2.5. Canada
6.2.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.5.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.2.5.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
6.3. Europe
6.3.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.3.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
6.3.4. U.K.
6.3.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.4.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.3.4.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
6.3.5. Germany
6.3.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.5.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.3.5.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
6.3.6. France
6.3.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.6.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.3.6.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
6.4. Asia Pacific
6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.4.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
6.4.4. China
6.4.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.4.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.4.4.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
6.4.5. India
6.4.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.5.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.4.5.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
6.4.6. Japan
6.4.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.6.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.4.6.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
6.4.7. South Korea
6.4.7.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.7.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.4.7.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
6.5. Latin America
6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.5.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
6.5.4. Brazil
6.5.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.4.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.5.4.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
6.5.5. Mexico
6.5.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.5.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.5.5.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
6.6. Middle East & Africa
6.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.6.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
6.6.4. UAE
6.6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.4.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.6.4.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
6.6.5. South Africa
6.6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.5.2. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
6.6.5.3. Historic Market Data & Future Forecasts, By Treatment, 2016-2027
Chapter 7. Company Profiles
7.1. Biogen Inc.
7.1.1. Company Description
7.1.2. Financial Highlights
7.1.3. Product Portfolio
7.1.4. Strategic Initiatives
7.2. Ionis Pharmaceuticals, Inc.
7.2.1. Company Description
7.2.2. Financial Highlights
7.2.3. Product Portfolio
7.2.4. Strategic Initiatives
7.3. Otsuka Pharmaceutical Co., Ltd.
7.3.1. Company Description
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. Strategic Initiatives
7.4. Sun Pharmaceutical
7.4.1. Company Description
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. Strategic Initiatives
7.5. F.Hoffmann-La Roche AG
7.5.1. Company Description
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. Strategic Initiatives
7.6. Biohaven Pharmaceutical
7.6.1. Company Description
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. Strategic Initiatives
7.7. Mitsubishi Tanabe Pharma Corporation
7.7.1. Company Description
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. Strategic Initiatives
7.8. AB Science
7.8.1. Company Description
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. Strategic Initiatives
7.9. Corestem
7.9.1. Company Description
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. Strategic Initiatives
7.10. BrainStorm Therapeutics
7.10.1. Company Description
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. Strategic Initiatives
List of Tables
Table 1 Amyotrophic Lateral Sclerosis Treatment Market Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 2 Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Region, 2016-2027 (USD Million)
Table 3 Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 4 Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 5 Hospital Pharmacies Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 6 Retail Pharmacies Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 7 Others Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 8 Medication Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 9 Stem Cell Therapy Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 10 Others Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 11 North America Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 12 North America Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 13 North America Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 14 U.S. Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 15 U.S. Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 16 U.S. Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 17 Canada Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 18 Canada Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 19 Canada Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 20 Europe Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 21 Europe Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 22 Europe Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 23 U.K. Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 24 U.K Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 25 U.K Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 26 Germany Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 27 Germany Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 28 Germany Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 29 France Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 30 France Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 31 France Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 32 Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 33 Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 34 Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 35 China Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 36 China Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 37 China Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 38 India Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 39 India Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 40 India Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 41 Japan Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 42 Japan Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 43 Japan Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 44 South Korea Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 45 South Korea Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 46 South Korea Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 47 Latin America Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 48 Latin America Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 49 Latin America Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 50 Brazil Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 51 Brazil Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 52 Brazil Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 53 Mexico Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 54 Mexico Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 55 Mexico Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 56 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 57 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 58 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 59 UAE Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 60 UAE Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 61 UAE Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
Table 62 South Africa Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 63 South Africa Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Million)
Table 64 South Africa Amyotrophic Lateral Sclerosis Treatment Market Data & Future Forecasts, By Treatment, 2016-2027 (USD Million)
List of Figures
Fig.1 Data Analysis Model
Fig.2 Amyotrophic Lateral Sclerosis Treatment Market, by 2016-2027 (USD Million)
Fig.3 Amyotrophic Lateral Sclerosis Treatment Market Segmentation
Fig.4 Supply chain analysis
Fig.5 Amyotrophic Lateral Sclerosis Treatment Market Driver Anlaysis
Fig.6 Amyotrophic Lateral Sclerosis Treatment Market Restraint Analysis
Fig.7 Amyotrophic Lateral Sclerosis Treatment Market Opportunity Analysis
Fig.8 Porters 5 Forces Model
Fig.9 PEST Analysis- Amyotrophic Lateral Sclerosis Treatment Market
Fig.10 Company Market Share Analysis, 2019

Amyotrophic Lateral Sclerosis Treatment Market Segmentation:

Amyotrophic Lateral Sclerosis Treatment Market, By Distribution Channel (2016-2027)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Amyotrophic Lateral Sclerosis Treatment Market, By Treatment (2016-2027)

  • Medication
  • Stem Cell Therapy
  • Others

Amyotrophic Lateral Sclerosis Treatment Market, By Region (2016-2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • South Africa

Major Players Operating in the Amyotrophic Lateral Sclerosis Treatment Market:

  • Biogen Inc.
  • Ionis Pharmaceuticals, Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Sun Pharmaceutical
  • Hoffmann-La Roche AG
  • Biohaven Pharmaceutical
  • Mitsubishi Tanabe Pharma Corporation
  • AB Science
  • Corestem
  • BrainStorm Therapeutics

Choose License Type

Single user
$3,960
Multi User
$4,950
Enterprise User
$5,940
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.